KEITH J. SULLIVAN

Corporate Board Profile

Tech Score: 0/100

CUTERA INC

Filing Date	Source Excerpt
2024-06-17	Mr. Sullivan currently serves as President and Chief Executive Officer of Neuronetics (NASDAQ: STIM), a publicly traded $105 million market cap company that develops non-invasive treatments for psychiatric disorders. Previously, he was Chief Commercial Officer and President (North America) of ZELTIQ Aesthetics, Inc. until the acquisition of ZELTIQ by Allergan, Inc. in April 2017. Mr. Sullivan held various other roles at ZELTIQ, including, Senior Vice President of Worldwide Sales and Marketing and Senior Vice President of Global Operation. Mr. Sullivan has also previously held leadership positions with Medicis Pharmaceuticals, Reliant Technologies, Medtronic (NYSE: MDT), Vision Quest Laser Center and Coherent Medical. Mr. Sullivan currently serves on the Board of Neuronetics (NASDAQ: STIM) and Venus Concept (NASDAQ: VERO). Mr. Sullivan earned a B.A. from the College of William and Mary where he currently serves as a Clinical Professor, a role he’s held since 2017.

Filing Date

Source Excerpt

2024-06-17

Mr. Sullivan currently serves as President and Chief Executive Officer of Neuronetics (NASDAQ: STIM), a publicly traded $105 million market cap company that develops non-invasive treatments for psychiatric disorders. Previously, he was Chief Commercial Officer and President (North America) of ZELTIQ Aesthetics, Inc. until the acquisition of ZELTIQ by Allergan, Inc. in April 2017. Mr. Sullivan held various other roles at ZELTIQ, including, Senior Vice President of Worldwide Sales and Marketing and Senior Vice President of Global Operation. Mr. Sullivan has also previously held leadership positions with Medicis Pharmaceuticals, Reliant Technologies, Medtronic (NYSE: MDT), Vision Quest Laser Center and Coherent Medical. Mr. Sullivan currently serves on the Board of Neuronetics (NASDAQ: STIM) and Venus Concept (NASDAQ: VERO). Mr. Sullivan earned a B.A. from the College of William and Mary where he currently serves as a Clinical Professor, a role he’s held since 2017.

Neuronetics, Inc.

Filing Date	Source Excerpt
2021-04-14	Mr. Sullivan received a Bachelor of Business Administration from the College of William and Mary. The Board believes Mr. Sullivan’s leadership role at our Company, responsibility for developing our strategic direction and management experience with medical product companies qualifies him to serve as a director on the Board.
2022-04-14	Mr. Sullivan received a Bachelor of Business Administration from the College of William and Mary.
2023-04-13	Mr. Sullivan has more than 30 years of senior sales leadership experience in the medical device industry.
2024-04-11	Mr. Sullivan received a Bachelor of Business Administration from the College of William and Mary. Mr. Sullivan has more than 30 years of senior sales leadership experience in the medical device industry.

Data sourced from SEC filings. Last updated: 2026-02-03